BRIEF published on 06/30/2025 at 22:35, 1 year 1 month ago Biophytis Delays Publication of 2024 Annual Financial Statements Biophytis Biotechnology Drug Development Annual Accounts Financial Delay
REGULATED PRESS RELEASE published on 06/30/2025 at 22:30, 1 year 1 month ago Information on the Annual Financial Statements Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company
PRESS RELEASE published on 06/30/2025 at 22:29, 1 year 1 month ago Information on the Annual Financial Statements Biophytis SA delays publication of 2024 annual accounts, aiming to release by July 7. The clinical-stage biotech company focuses on age-related disease treatments Biotechnology Company Clinical-stage Biophytis SA Age-related Diseases 2024 Annual Accounts
BRIEF published on 06/19/2025 at 23:05, 1 year 1 month ago Biophytis Temporarily Suspends Share Trading Biophytis Regulatory Compliance Financial Report Euronext Growth Share Suspension
REGULATED PRESS RELEASE published on 06/19/2025 at 23:00, 1 year 1 month ago Biophytis announces the temporary suspension of the trading of its shares Biophytis announces temporary suspension of trading shares on Euronext due to delayed financial report. Expected to resume after report publication. Company info included Biophytis Euronext Trading Financial Report Suspension
PRESS RELEASE published on 06/19/2025 at 22:59, 1 year 1 month ago Biophytis announces the temporary suspension of the trading of its shares Biophytis announces temporary suspension of trading of its shares by Euronext due to non-publication of annual financial report for 2024, expected to resume after report publication Biophytis Shares Euronext Trading Suspension
BRIEF published on 06/04/2025 at 07:05, 1 year 2 months ago Biophytis to Attend BIO International Convention in Boston Biophytis Biotechnology Partnerships BIO101 Convention
REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 1 year 2 months ago Biophytis announces its participation in the BIO International Convention from June 16 to 19 Biophytis announces participation in BIO International Convention from June 16 to 19, 2025 in Boston, USA. Focus on drug candidate BIO101 and potential partnerships Biophytis Biotechnology Partnerships BIO International Convention Drug Candidate
BRIEF published on 05/30/2025 at 22:05, 1 year 2 months ago Biophytis Delays 2024 Annual Financial Report Publication Financial Statements Biophytis Shareholder Meeting Age-related Diseases Audit Delay
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 1 year 2 months ago Information on the Annual Financial Statements Biophytis postpones the publication of its 2024 annual financial statements due to technical complications in the audit process. The Company aims to complete the audit by the end of June 2025 Biophytis Audit Postponement 2024 Annual Financial Statements Technical Complications
Published on 08/11/2026 at 00:40, 5 hours 52 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 6 hours 7 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 6 hours 57 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 7 hours 2 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/10/2026 at 23:25, 7 hours 7 minutes ago Ur-Energy Reports Second Quarter 2026 Results
Published on 08/10/2026 at 22:15, 8 hours 17 minutes ago Amrize Files Form 10-Q for Second Quarter 2026
Published on 08/10/2026 at 22:05, 8 hours 27 minutes ago Immunic Appoints Elena Ridloff to Board of Directors
Published on 08/10/2026 at 20:24, 10 hours 8 minutes ago EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 10 hours 57 minutes ago Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 18:29, 12 hours 2 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/10/2026 at 18:00, 12 hours 32 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 18 hours 38 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 18 hours 56 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 21 hours 10 minutes ago Number of shares and voting rights - July 2026 (In French only)
